HOME > ARCHIVE

ARCHIVE

JPMA to Start Full-Scale Discussions on New Drug Pricing

January 24, 2005
PMDA's Performance in 1st Half of FY2004 Announced

January 24, 2005
BUSINESS NEWS IN BRIEF

January 24, 2005
Designation of Prescription Drugs Proceeding as Planned: Korosho

January 24, 2005
WEBSITE NEWS

January 24, 2005
Full-scale Discussions on Revision of Medical Service Law to Begin in Autumn

January 24, 2005
NEW PRODUCTS

January 24, 2005
METI's Draft Budget Earmarks \3.55 Bil. for Service Industry Creation

January 17, 2005
REGULATORY NEWS IN BRIEF

January 17, 2005
Meet the Leaders (39)

January 17, 2005
WEBSITE NEWS

January 17, 2005
MEETING

January 17, 2005
BULLTEIN

January 17, 2005
New Year's Commentary -1-

January 17, 2005
RESEARCH & DEVELOPMENT NEWS IN BRIEF

January 17, 2005
New Year's Commentary -2-

January 17, 2005
OTC NEWS IN BRIEF

January 17, 2005
Emerging New Therapeutics against Hypercholesterolemia and Atherosclerosis: Lipitor, a Golden Standard?

January 17, 2005
DIAGNOSTIC NEWS IN BRIEF

January 17, 2005
Kyorin to Accelerate Drug Discovery by Acquiring ABI

January 17, 2005

ページ

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COLUMN

Strategic Talent Acquisition in the Japanese Life Sciences Sector: Your Market Intelligence Briefing

By Philip Carrigan

Focus: How to Get the Talent You Need in a Tough MarketThe Japanese life sciences sector presents a challenging landscape for global companies. To succeed, you must move beyond reactive hiring and adopt a truly strategic talent acquisition model. Our…